Pilot study of newborn screening of inborn error of metabolism using tandem mass spectrometry in Malaysia: outcome and challenges
-
Zabedah Md. Yunus
,
Salina Abdul Rahman
Abstract
Background:
The aim of this study was to determine the feasibility of performing newborn screening (NBS) of inborn errors of metabolism (IEMs) using tandem mass spectrometry (TMS) and the impact on its detection rate in Malaysia.
Methods:
During the study period between June 2006 and December 2008, 30,247 newborns from 11 major public hospitals in Malaysia were screened for 27 inborn errors of amino acid, organic acid and fatty acid metabolism by TMS. Dried blood spot (DBS) samples were collected between 24 h and 7 days with parental consent. Samples with abnormal results were repeated and the babies were recalled to confirm the diagnosis with follow-up testing.
Results:
Cut-off values for amino acids and acylcarnitines were established. Eight newborns were confirmed to have IEM: two newborns with Maple syrup urine disease (MSUD), two with methylmalonic aciduria (MMA) one with ethylmalonic aciduria, two with argininosuccinic aciduria and one with isovaleric aciduria. Diagnosis was missed in two newborns. The detection rate of IEMs in this study was one in 2916 newborns. The sensitivity and specificity of TMS were 80% and 99%, respectively.
Conclusions:
IEMs are common in Malaysia. NBS of IEMs by TMS is a valuable preventive strategy by enabling the diagnosis and early treatment of IEM before the onset of symptoms aiming at prevention of mental retardation and physical handicap. A number of shortcomings warrant further solution so that in near future NBS for IEMs will become a standard of care for all babies in Malaysia in tandem with the developed world.
Acknowledgments
We thank the Director General of Health Malaysia for permission to publish this article. Our special thanks to Dr. Shahnaz Murad (Director of IMR) for approval of the research grant and Dr. Rohani Md Yasin (Centre Head, SDC) for critical reading of the research proposal and valuable comments. We would like to extend our gratitude to all clinicians, nurses and midwives from the 11 participating hospitals for their valuable contributions in this study. Our gratitude also extends to the staff of Newborn Screening Laboratory in Biochemistry Unit, IMR.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted article and approved submission.
Research funding: This study was funded by Research Grant from Institute for Medical Research, Ministry of Health Malaysia (Grant / Award Number: ‘MRG-2006-004’).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in thestudy design; in the collection, analysis, and interpretationof data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and molecular bases of inherited diseases, 8th ed. New York: McGraw-Hill, 2001.Suche in Google Scholar
2. Mak CM, Lee HC, Chan AY, Lam CW. Inborn errors of metabolism and expanded newborn screening: review and update. Crit Rev Clin Lab Sci 2013;50:142–62.10.3109/10408363.2013.847896Suche in Google Scholar PubMed
3. Blau N, Hoffmann GF, Leonard J, Clarke JT. Physician’s guide to the treatment and follow-up of metabolic diseases. Heidelberg: Springer, 2005.10.1007/3-540-28962-3Suche in Google Scholar
4. Leonard JV. Komrower lecture: treatment of inborn errors of metabolism: a review. J Inherit Metab Dis 2006;29:275–8.10.1007/s10545-006-0273-4Suche in Google Scholar PubMed
5. Thong MK, Yunus ZM. Spectrum of inherited metabolic disorders in Malaysia. Ann Acad Med Singapore 2008;37(Suppl 3):66–70.Suche in Google Scholar
6. Yunus ZM, Kamaludin DA, Mamat M, Choy YS, Ngu LH. Clinical and biochemical profiles of maple syrup urine disease in malaysian children. JIMD Rep 2012;5:99–107.10.1007/8904_2011_105Suche in Google Scholar PubMed PubMed Central
7. Chen BC, Ngu LH, Zabedah MY. Argininosuccinic aciduria: clinical and biochemical phenotype findings in Malaysian children. Malaysian J Pathol 2010;32:87–95.10.1002/path.2690Suche in Google Scholar PubMed
8. Chace DH, Hillman SL, Van Hove JL, Naylor EW. Rapid dagnosis of MCAD deficiency: quantitative analysis of octanoylcarnitine and other acylcarnitines in newborn blood spots by tandem mass spectrometry. Clin Chem 1997;43:2106–13.10.1093/clinchem/43.11.2106Suche in Google Scholar
9. Chace DH, Kalas TA, Naylor EW. Use of tandem mass spectrometry for multianalyte screening of dried blood samples from newborns. Clin Chem 2003;49:1797–817.10.1373/clinchem.2003.022178Suche in Google Scholar PubMed
10. Clayton PT. Application of mass spectrometry in the study of inborn errors of metabolism. J Inherit Metab Dis 2001;24:139–50.10.1023/A:1010358715835Suche in Google Scholar
11. Ghoshal AK, Guo T, Soukhova N, Soldin SJ. Rapid measurement of plasma acylcarnitines by liquid chromatography-tandem mass spectrometry without derivatization. Clinica Chimica Acta 2005;358:104–12.10.1016/j.cccn.2005.02.011Suche in Google Scholar PubMed
12. Rashed MS, Bucknall MP, Little D, Awad A, Jacob M, et al. Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles. Clin Chem 1997;43:1129–41.10.1093/clinchem/43.7.1129Suche in Google Scholar
13. Yoon HR, Lee KR, Kang S, Lee DH, Yoo HW, et al. Screening of newborns and high-risk group of children for inborn metabolic disorders using tandem mass spectrometry in South Korea: a three-year report. Clinica Chimica Acta 2005;354:167–80.10.1016/j.cccn.2004.11.032Suche in Google Scholar PubMed
14. Lim JS, Tan ES, John CM, Poh S, Yeo SJ, et al. Inborn error of metabolism (IEM) screening in Singapore by electrospray ionization-tandem mass spectrometry (ESI/MS/MS): an 8 year journey from pilot to current program. Mol Genet Metab 2014;113:53–61.10.1016/j.ymgme.2014.07.018Suche in Google Scholar PubMed
15. Niu D-M, Chien Y-H, Chiang C-C, Ho H-C, Hwu W-L, et al. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan. J Inherit Metab Dis 2010;33(Suppl 2):S295–305.10.1007/s10545-010-9129-zSuche in Google Scholar PubMed
16. Yamaguchi S, Purevsuren J, Hasegawa T, Kobayashi H, Mushimoto Y, et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency and Expanded Newborn Screening in Japan, Featured presentation at Newborn Screening and Genetic Testing Symposium and the International Society for Neonatal Screening, Atlanta, May 5 to 10, 2013, Available at: http://www.aphl.org/conferences/proceedings/Documents/2013/2013-Newborn-Screening-Symposium/59Yamaguchi.pdf.Suche in Google Scholar
17. Shi X-T, Cai J, Wang Y-Y, Tu W-J, Wang W-P, et al. Newborn screening for inborn errors of metabolism in Mainland China: 30 years of experience, JIMD Rep 2012;6:79–83.10.1007/8904_2011_119Suche in Google Scholar PubMed PubMed Central
18. McHugh D, Cameron CA, Abdenur JE, Abdulrahman M, Adair O, et al. Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: A worldwide collaborative project. Genet Med 2011;13:230–54.10.1097/GIM.0b013e31820d5e67Suche in Google Scholar PubMed
19. Zytkovicz TH, Fitzgerald EF, Marsden D, Larson CA, Shih VE, et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem 2001;47:1945–55.10.1093/clinchem/47.11.1945Suche in Google Scholar
20. Walter JH, Patterson A, Till J, Besley GT, Fleming G, et al. Bloodspot, acylcarnitine and amino acid analysis in cord blood samples: efficacy and reference, data from a large cohort study. J Inherit Metab Dis 2009;32:95–101.10.1007/s10545-008-1047-ySuche in Google Scholar PubMed
21. Vital Statistic Malaysia 2014, population and demography. Available at: https://www.statistics.gov.my/index.php?r=column/cthemeByCat&cat=165&bul_id=akZOby9EYThSQ3V3WHpZSEdjeU50dz09&menu_id=L0pheU43NWJwRWVSZklWdzQ4TlhUUT09.Suche in Google Scholar
©2016 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Review
- A germline mutation of HRPT2/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature
- Original Articles
- Seroprotection status of hepatitis B and measles vaccines in children with type 1 diabetes mellitus
- Prevalence and awareness of functional and structural foot abnormalities in children and adolescents with type 1 diabetes
- WHO European Childhood Obesity Surveillance Initiative in Serbia: a prevalence of overweight and obesity among 6–9-year-old school children
- Pilot study of newborn screening of inborn error of metabolism using tandem mass spectrometry in Malaysia: outcome and challenges
- In children with autoimmune thyroid diseases the association with Down syndrome can modify the clustering of extra-thyroidal autoimmune disorders
- Identification of monogenic gene mutations in Japanese subjects diagnosed with type 1B diabetes between >5 and 15.1 years of age
- Referral pattern of children with short stature to a pediatric endocrine clinic in Kuwait
- Factors associated with post-menarcheal growth: results of a longitudinal study in Chilean girls from different socioeconomic statuses
- Percentiles for anthropometric measures in Iranian children and adolescents: the CASPIAN-IV study
- Hormone disorder and vitamin deficiency in attention deficit hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs)
- Case Reports
- Hyperinsulinism-hyperammonemia syndrome: a de novo mutation of the GLUD1 gene in twins and a review of the literature
- Novel homozygous likely-pathogenic intronic variant in INS causing permanent neonatal diabetes in siblings
- A girl with permanent neonatal diabetes due to KCNJ11 mutation presented with Mauriac syndrome after improper adjustment in sulfonylurea dosage over 6 years
- Treatment experience and long-term follow-up data in two severe neonatal hyperparathyroidism cases
- A novel splice site mutation of FGD1 gene in an Aarskog-Scott syndrome patient with a large anterior fontanel
Artikel in diesem Heft
- Frontmatter
- Review
- A germline mutation of HRPT2/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature
- Original Articles
- Seroprotection status of hepatitis B and measles vaccines in children with type 1 diabetes mellitus
- Prevalence and awareness of functional and structural foot abnormalities in children and adolescents with type 1 diabetes
- WHO European Childhood Obesity Surveillance Initiative in Serbia: a prevalence of overweight and obesity among 6–9-year-old school children
- Pilot study of newborn screening of inborn error of metabolism using tandem mass spectrometry in Malaysia: outcome and challenges
- In children with autoimmune thyroid diseases the association with Down syndrome can modify the clustering of extra-thyroidal autoimmune disorders
- Identification of monogenic gene mutations in Japanese subjects diagnosed with type 1B diabetes between >5 and 15.1 years of age
- Referral pattern of children with short stature to a pediatric endocrine clinic in Kuwait
- Factors associated with post-menarcheal growth: results of a longitudinal study in Chilean girls from different socioeconomic statuses
- Percentiles for anthropometric measures in Iranian children and adolescents: the CASPIAN-IV study
- Hormone disorder and vitamin deficiency in attention deficit hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs)
- Case Reports
- Hyperinsulinism-hyperammonemia syndrome: a de novo mutation of the GLUD1 gene in twins and a review of the literature
- Novel homozygous likely-pathogenic intronic variant in INS causing permanent neonatal diabetes in siblings
- A girl with permanent neonatal diabetes due to KCNJ11 mutation presented with Mauriac syndrome after improper adjustment in sulfonylurea dosage over 6 years
- Treatment experience and long-term follow-up data in two severe neonatal hyperparathyroidism cases
- A novel splice site mutation of FGD1 gene in an Aarskog-Scott syndrome patient with a large anterior fontanel
